ArticleFrontiers in oncology2026

Low-dose decitabine combined with camrelizumab for refractory/relapsed mycosis fungoides/Sézary syndrome: a retrospective exploratory study.

Shan Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.